Chapter 42. Follicular Lymphoma
- Mark A. Crowther MD, MSc, FRCPC Professor Division Director4,5,
- Jeff Ginsberg MD, FRCPC Professor6,
- Holger J. Schünemann MD, PhD, MSc, FACP, FCCP Professor7,8,
- Ralph M. Meyer MD, FRCPC Director Professor9,10,
- Richard Lottenberg MD, FACP Professor11
Published Online: 4 FEB 2009
DOI: 10.1002/9781444300857.ch42
Copyright © 2008 Blackwell Publishing Ltd
Book Title

Evidence-Based Hematology
Additional Information
How to Cite
Imrie, K. and Cheung, M. (2009) Follicular Lymphoma, in Evidence-Based Hematology (eds M. A. Crowther, J. Ginsberg, H. J. Schünemann, R. M. Meyer and R. Lottenberg), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444300857.ch42
Editor Information
- 4
Division of Hematology, McMaster University, Hamilton, Ontario, Canada
- 5
St. Joseph's Hospital, Hamilton, Ontario, Canada
- 6
Department of Medicine, McMaster University, Hamilton, Canada
- 7
CLARITY Research Group, Department of Epidemiology, Italian National Cancer Institute Regina Elena, Rome, Italy
- 8
McMaster University, Hamilton, Canada
- 9
National Cancer Institute of Canada, Clinical Trials Group, Edith Eisenhauer Chair in Clinical Cancer Research, Queen's University, Kingston, Ontario, Canada
- 10
Departments of Oncology and Medicine, Queen's University, Kingston, Ontario, Canada
- 11
Division of Hematology/Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
Publication History
- Published Online: 4 FEB 2009
- Published Print: 27 JUN 2008
ISBN Information
Print ISBN: 9781405157476
Online ISBN: 9781444300857
- Summary
- Chapter
Keywords:
- Follicular lymphoma (FL) - second most common subtype of non-Hodgkin's lymphoma;
- systematic reviews and meta-analyses;
- limited stage follicular lymphoma and systemic therapy;
- chemotherapy regimen;
- role of interferon;
- aggressive chemotherapy with ProMACE-MOPP and total nodal irradiation;
- role of rituximab in FL;
- rituximab as maintenance therapy for patients with indolent B-cell lymphomas;
- radioimmunoconjugate therapy;
- autologous stem cell transplantation (ASCT) following myeloablative therapy
Summary
This chapter contains sections titled:
Introduction
Literature-search strategy and inclusion
Search results
Systematic reviews and meta-analyses
Acknowledgment
References
